simendan has been researched along with Cardiomyopathy, Congestive in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 10 (58.82) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avcı, E; Kırış, T | 1 |
| Almeida, GR; Bernardo, WM; Buzzini, RF; Floriano, I; Silvinato, A | 1 |
| Kumar, A; Kushwah, S; Sahana, KS | 1 |
| Mattila, N; Nyblom, O; Rahkonen, O; Rautiainen, P; Suominen, P; Turanlahti, M | 1 |
| Beiras-Fernandez, A; Kaczmarek, I; Kur, F; Reichart, B; Schmoeckel, M; Weis, FC; Weis, M | 1 |
| Bertram, H; Görler, H; Happel, CM; Hitz, MP; Köditz, H; Wessel, A; Yelbuz, TM | 1 |
| Beiras-Fernandez, A; Hauer, D; Kur, F; Schmoeckel, M; Weis, FC; Weis, M | 1 |
| Asencio, Y; Bordes, J; Goutorbe, P; Jego, C; Kenane, N; Meaudre, E; Montcriol, A; Palmier, B | 1 |
| Alsina, E; Brogly, N; Gilsanz, F; Guasch, E; López, T; Puertas, L | 1 |
| Gautreux Minaya, S; Lobo Martínez, P; Oulego Erroz, I; Rodríguez Fernández, LM | 1 |
| Braun, JP; Dohmen, P; Döpfmer, U; Schneider, M | 1 |
| Nanas, JN; Tsagalou, EP | 1 |
| Cam, N; Kasikcioglu, E; Kasikcioglu, HA; Ozturk, R; Tartan, Z; Uyarel, H | 1 |
| Flevari, P; Kourea, K; Kremastinos, DT; Leftheriotis, D; Panou, F; Parissis, JT | 1 |
| Andreou, C; Colucci, WS; Conrad, CH; Givertz, MM | 1 |
| Bredin, F; Franco-Cereceda, A | 1 |
| Hettrick, DA; Jamali, IN; Lowe, D; McGough, MF; Pagel, PS; Tessmer, JP; Warltier, DC | 1 |
1 review(s) available for simendan and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Decompensated congestive heart failure - treatment with levosimendan.
Topics: Brazil; Cardiomyopathy, Dilated; Cardiotonic Agents; Clinical Decision-Making; Heart Failure; Humans; Reproducibility of Results; Risk Factors; Simendan; Treatment Outcome | 2019 |
4 trial(s) available for simendan and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Short-term effects of levosimendan on strain/strain rate markers in patients with nonischemic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Echocardiography; Female; Humans; Male; Middle Aged; Simendan; Treatment Outcome; Ventricular Function, Left | 2018 |
Do calcium sensitizers affect right ventricular functions in patients with chronic heart failure?
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Echocardiography, Doppler; Humans; Hydrazones; Middle Aged; Pyridazines; Simendan; Treatment Outcome; Tricuspid Valve; Ventricular Function, Right | 2007 |
Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nervous System; Cardiomyopathy, Dilated; Cardiotonic Agents; Female; Heart Failure; Humans; Hydrazones; Male; Natriuretic Peptide, Brain; Pyridazines; Simendan; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left | 2006 |
Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
Topics: Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Circulation; Dose-Response Relationship, Drug; Heart; Heart Function Tests; Heart Rate; Humans; Hydrazones; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Contraction; Pyridazines; Simendan; Ventricular Dysfunction, Left | 2007 |
12 other study(ies) available for simendan and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Levosimendan. A promising future drug for refractory cardiac failure in children?
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Child; Electrocardiography; Female; Heart Failure; Humans; Hydrazones; Myocardial Contraction; Myocarditis; Pyridazines; Simendan | 2016 |
The Hemodynamic Effects and Safety of Repetitive Levosimendan Infusions on Children With Dilated Cardiomyopathy.
Topics: Adolescent; Cardiomyopathy, Dilated; Cardiotonic Agents; Child; Child, Preschool; Echocardiography; Female; Follow-Up Studies; Hemodynamics; Humans; Hydrazones; Infant; Infusions, Intravenous; Male; Pyridazines; Retrospective Studies; Simendan | 2017 |
Primary graft failure and Ca2+ sensitizers after heart transplantation.
Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cardiotonic Agents; Echocardiography, Transesophageal; Electrocardiography; Extracorporeal Membrane Oxygenation; Female; Heart Transplantation; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Stroke Volume; Treatment Failure | 2008 |
Levosimendan for bridging in a pediatric patient with Alström syndrome awaiting heart-lung transplantation.
Topics: Abnormalities, Multiple; Adolescent; Cardiomyopathy, Dilated; Cardiotonic Agents; Cell Cycle Proteins; Heart-Lung Transplantation; Humans; Hydrazones; Hypertension, Pulmonary; Male; Proteins; Pyridazines; Simendan; Syndrome; Treatment Outcome; Waiting Lists | 2008 |
The management of severe primary graft failure after cardiac transplantation.
Topics: Cardiomyopathy, Dilated; Cardiopulmonary Bypass; Extracorporeal Membrane Oxygenation; Graft Survival; Heart Transplantation; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Postoperative Complications; Pyridazines; Simendan; Treatment Failure; Vasodilator Agents | 2009 |
Weaning failure from mechanical ventilation due to dilated cardiomyopathy: successful use of levosimendan.
Topics: Cardiomyopathy, Dilated; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Respiration, Artificial; Simendan | 2009 |
[Acute early postpartum cardiac failure associated with dilated cardiomyopathy: successful treatment with intra-aortic balloon counter-pulsation and levosimendan].
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cesarean Section; Echocardiography; Female; Heart Failure; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Postpartum Period; Pregnancy; Pyridazines; Simendan; Stroke Volume; Ventricular Function, Left | 2010 |
Treatment of acute heart failure using levosimendan for a patient with dilated cardiomyopathy, chronic renal failure, and hypertension.
Topics: Acute Disease; Adolescent; Cardiomyopathy, Dilated; Cardiotonic Agents; Diuresis; Dose-Response Relationship, Drug; Echocardiography, Doppler, Pulsed; Follow-Up Studies; Glycogen Storage Disease Type I; Heart Failure; Humans; Hydrazones; Hypertension; Infusions, Intravenous; Kidney Failure, Chronic; Male; Myocardial Contraction; Pyridazines; Simendan; Stroke Volume | 2011 |
Successful treatment of dilative cardiomyopathy in a 12-year-old girl using the calcium sensitizer levosimendan after weaning from mechanical biventricular assist support.
Topics: Anti-Bacterial Agents; Antifungal Agents; Calcium; Candidiasis; Cardiomyopathy, Dilated; Cardiotonic Agents; Child; Cross Infection; Echocardiography; Female; Fluconazole; Heart Ventricles; Heart-Assist Devices; Humans; Hydrazones; Immunoglobulins; Intubation, Intratracheal; Myocarditis; Pyridazines; Simendan; Time Factors; Treatment Outcome; Ventricular Function, Left | 2004 |
Resuscitation from adrenaline resistant electro-mechanical dissociation facilitated by levosimendan in a young man with idiopathic dilated cardiomyopathy.
Topics: Adult; Cardiomyopathy, Dilated; Cardiopulmonary Resuscitation; Cardiotonic Agents; Epinephrine; Heart Arrest; Heart Failure; Humans; Hydrazones; Male; Pyridazines; Simendan | 2006 |
Experiences of levosimendan as an inotropic agent in conjunction with passive containment surgery.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiac Surgical Procedures; Cardiomyopathy, Dilated; Cardiotonic Agents; Drug Administration Schedule; Female; Heart Rate; Heart-Assist Devices; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Retrospective Studies; Simendan; Treatment Outcome | 2007 |
Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy.
Topics: Animals; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Cardiotonic Agents; Diastole; Dogs; Hemodynamics; Hydrazones; Kinetics; Myocardial Contraction; Myocardium; Oxygen Consumption; Pyridazines; Simendan; Systole; Ventricular Function, Left | 1997 |